Anhui Yikangda optoelectronics Technology Co., Ltd. was founded bybiomedical optical innovation team, Chinese Academy of Sciences. The company integrates research and development, production and sales of innovative biomedical optical products. It has mastered a number of key technologies with independent intellectual property rights in the fields of early screening for chronic diseases, genetic analysis and diagnosis and medical optical imaging.
Yikangda relies on the Wanjiang Emerging Industry Technology Development Center which is established by Hefei Institutes of Physical Science,Chinese Academy of Sciences, Tongling government , Anhui Science and Technology Agency. We has established close coperation with Chinese Academy of Sciences, University of Science and Technology of China, China Agricultural University, University of Manitoba and other top research institutions at home and abroad. And also we has established clinical research cooperation with The General Hospital of the People's Liberation Army(PLAGH), Peking Union Medical College Hospital, Anhui Provincial Hospital,First Affiliated Hospital ofAnhui Medical University , First Affiliated Hospital of Anhui University of Chinese Medicine, Seven Oaks General Hospital in Canada and other well-known hospitals at home and abroad. In 2013, we, together with Wanjiang Center, Anhui Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, and Anhui Provincial Hospital, were approved to set up Anhui Biomedical Optical Instrument Engineering Technology Research Center which effectively promoted key technologies, core components and innovation of biomedical optical instrument and equipment.
We, the company, has strong research and development(R&D) capabilities. There are more than 30% of R&D personnel have doctor degree with elite schools. We hold more than 10 invention patents and software copyrights. The company creatively applied fluorescence spectroscopy to the detection and assessment of diabetes mellitus and its chronic complications. The micro-nano technology was applied to the on-site detection of pathogenic microorganisms, and developed an integrated, intelligent non-invasive diabetes detector and microfluidic real-time fluorescence PCR instrument. Our technical indicators of products have reached the market advanced level.
Looking ahead, we will maintain our professional and innovative features, and focus on the needs of health, we will strive to become a supplier of biomedical optics instrument with advanced technology.